EU Matchmaking Event: Development and production of COVID-19 therapeutics
The European Commission will facilitate cooperation between actors in the supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible. In the context of a surge in demand, it remains crucial to ensure the speedy production of current and new therapeutics against COVID-19. To support the industry, the Commission organises the pan-EU matchmaking events for all supply chain actors, so that they find solutions for the bottlenecks encountered.
Medicines for COVID-19 are still in the development phase. Therefore, the objective of the event is to help accelerate the development of new and repurposed medicines for COVID-19 therapeutics, i.e. medicines specifically developed for an indication in treatment of COVID-19, at all stages of COVID-19 disease and mobilise the EU pharma manufacturing capacity for their potential production.
The target group is the entire EU COVID-19 therapeutics value chain starting with researchers and developers, through manufacturing companies and representatives of the hospitals, who apply such therapeutics to their patients. The providers of ancillary functions such as clinical trials services, accessories suppliers (e.g. vials, syringes, tubes etc.), funding providers and public procurers will also be targeted to take part in the event.
The event will take place virtually on 12th and 13th July 2021. 12th July will start with a half-day seminar setting the scene with a welcome by Commissioner Breton and Commissioner Kyriakides.
The European Clusters Alliance, the Council of European BioRegions, and the European Cluster Collaboration Platform are collaborating with the European Commission on this event.
Interested organisations can now submit their expression of interest to participate: Register until 25th June 2021